M. Manzano

L. Rodrigo, R. Pérez-López, R. Solá, 2012, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study

Martín Prieto, M. Buti, J. Calleja, 2017, PloS one.

Prevents HBV Reactivation with Tenofovir in Anti-HBC Positive Patients with Hematologic Malignancies Treated with Rituximab. Results Final Visit 18-Months (Preblin Study)

Mayda Martínez Rodríguez, M. Buti, J. Calleja, 2016 .

P1058 LONG-TERM EFFICACY OF TENOFOVIR IN PREVIOUSLY TREATED AND NAIVE PATIENTS. RESULTS FROM THE SPANISH CHRONIC HEPATITIS B REGISTRY (CIBERHEP)

J. J. Moreno, M. Buti, J. Sánchez-Tapias, 2014 .

Late reactivation of occult hepatitis B virus infection in a patient with chronic lymphocytic leukemia after rituximab and fludarabine-based regimen

I. Fernández, R. Muñoz, G. Castellano, 2015, Leukemia & lymphoma.

Diagnostic accuracy of liver and spleen stiffness measured by fibroscan® in the prediction of esophageal varices in HCV-related cirrhosis patients treated with oral antivirals.

I. Fernández, R. Muñoz, G. Castellano, 2020, Gastroenterologia y hepatologia.

Diagnostic accuracy of liver and spleen stiffness measured by fibroscan® in the prediction of esophageal varices in HCV-related cirrhosis patients treated with oral antivirals

I. Fernández, R. Muñoz, G. Castellano, 2022, Gastroenterología y Hepatología (English Edition).

Hepatocellular carcinoma risk in hepatitis C stage‐3 fibrosis after sustained virological response with direct‐acting antivirals

C. Fernández-Rodríguez, L. Bonet, G. Cuevas, 2021, Liver international : official journal of the International Association for the Study of the Liver.

[Celiac disease and Bud-Chiari syndrome: an uncommon association].

C. Garfia, J. Manzanares, G. Castellano, 2002, Gastroenterologia y hepatologia.

Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk

V. Carreño, U. Hedner, J. Quiroga, 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study

R. Andrade, J. M. Rosales, J. Calleja, 2022, Gastroenterología y Hepatología (English Edition).

R. Andrade, J. M. Rosales, J. Calleja, 2021, Gastroenterologia y hepatologia.

P1040 TENOFOVIR FOR THE PROPHYLAXIS OF HBV REACTIVATION IN ANTI-HBC-POSITIVE PATIENTS WITH HEMATOLOGIC MALIGNANCIES TREATED WITH RITUXIMAB: PRELIMINARY RESULTS OF A RANDOMIZED STUDY (PREBLIN STUDY)

M. Buti, R. Esteban, M. García-Retortillo, 2014 .

[Association of hyperhomocysteinemia with liver steatosis in patients with chronic hepatitis C].

D. Lora, I. Fernández, G. Castellano, 2011, Medicina clinica.

Idiopathic thrombocytopenic purpura and pancytopenia in a patient with Crohn's disease: a new association.

M. Manzano, C. Yela, S. Ja, 1996, American Journal of Gastroenterology.